Nemaura Medical Investor Presentation Deck slide image

Nemaura Medical Investor Presentation Deck

Product Positioning - Medical sugarBEATⓇ CGM sales through Licensee(s) - no further marketing spend required on Nemaura's part thus minimizing cost of sales. Support UK Licensee: Licensee engaged in studies designed to support reimbursement from the UK government. Middle East: SFDA Approval achieved. Orders for 1.7 million sensors and 17,000 transmitters received and undergoing scheduling of delivery upon finalization of launch plans.
View entire presentation